![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 27-Sep-2011[ | E-mail |
Share ] Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Media alert
Media have less than three weeks to register for Europe's largest cancer congress: The 2011 European Multidisciplinary Cancer Congress in Stockholm, 23-27 September 2011. To register, go to: www.ecco-org.eu
The 2011 European Multidisciplinary Cancer Congress will take place at the Stockholmsmssan (Stockholm International Fairs), Stockholm, Sweden, (www.stofair.se) from Friday 23 September to Tuesday 27 September 2011.
There will be over 2,000 presentations and around 16,000 participants from 120 countries, making it the largest European cancer congress to date. It is the only cancer congress in Europe to offer presentations of cutting-edge research across the whole cancer field, and will include basic and translational research, first reports from high quality phase II and III clinical trials, epidemiology and much more. In addition, for the first time there will be five new tracks, including industry and "oncotechnology". The "oncopolicy" track launched at the 2009 congress will continue to tackle issues of prime importance to the European cancer community, as well as helping to inform European policy and ensuring cancer's place at the top of the EU health and research policy agenda.
There will be media news briefings at the following times:
Friday 23 September: 13.00 hrs CEST Swedish language news briefing for local journalists
Friday 23 September: 17.00 hrs CEST Opening press conference
Saturday 24 September: 08.00 hrs CEST
Sunday 25 September: 08.00 hrs CEST
Monday 26 September: 08.00 hrs CEST
Monday 26 September: 11.15 hrs CEST
With the exception of the first press conference in Swedish for the local journalists, all other press conferences will be in English.
Here is a sample of some of the news to be announced at the congress (all information is embargoed):
- Is there a relationship between high blood pressure and the risk of developing or dying from cancer?
- New way of delivering treatment directly to the liver delivers extra months of disease-free life for melanoma patients
- Giving chemotherapy to pregnant women: what is the effect on their children?
- One size may not fit all: regular checks needed through the course of cancer to determine changes in tumour make-up and identify appropriate treatment
- New treatment can delay the onset of bone metastases in prostate cancer
- Results from two new Phase III trials reveal new ways of relieving pain from bone metastases in prostate cancer patients, and of improving their overall survival
- Results from phase III international trial shows significant benefits in quality of life for prostate cancer patients treated with new drug
- New drug combination can delay breast cancer progression in patients with advanced disease
- Potentially practice-changing results of major UK trial combining radiotherapy with chemotherapy in women with early breast cancer
- Latest update from the BIG 1-98 trial on the use of letrozole in post-menopausal women with early breast cancer
- Could smaller, faster trials improve patient survival by making new drugs available more quickly?
- Radical changes needed to develop equitable, affordable cancer care for all
- Standardising clinical practice across Europe: treatment of rectal cancer varies enormously between different countries
- Researchers discover gene that is mutated in some blood cancers and predicts better survival
- Two new, cost-effective ways to predict prostate cancer
- Elderly breast cancer patients are at risk of treatment discrimination
- Results from phase III trial of everolimus combined with exemestane: new hope for post-menopausal women with advanced breast cancer resistant to hormone therapy
- Does zoledronic acid added to standard adjuvant therapy reduce risk of recurrence in breast cancer patients?
Opening times for the congress press office in Stockholm and telephone numbers:
Friday 23 September 09.00 19.00 hrs (CEST)
Saturday 24 Monday 26 September 07.30 18.00 hrs
Tuesday 27 September 08.00 14.00 hrs
Tel: +46 (0)8 727 2107, +46 (0)8 727 2108 or +46 (0)8 727 2109
Fax: +46 (0)8 727 2138
Press officers: Emma Mason, Mary Rice, Kay Roche, Saffina Rana, Lisa Lnner Pulkkinen
The majority of the abstracts will be published online at 12.00 hrs CEST on Monday 12 September and can be reported from this time. You can find them at: http://stockholm2011.ecco-org.eu/programmesearch
However, any abstracts that are in the official media programme or that are late-breaking or "best" abstracts will not be published online until the day of presentation at the congress and are embargoed until that day.
###
ECCO (the European CanCer Organisation, which is organising the congress), ESMO and ESTRO welcome the interest of the press in cancer issues and are happy to provide full assistance to journalists attending the 2011 Stockholm congress, or using the congress website as a resource in their coverage of cancer issues. A media centre with computing, fax, photocopying and free international phone and internet connections will be available.
Follow us on Twitter: #emcc2011
Registration and hotel accommodation
The 2011 European Multidisciplinary Cancer Congress is open to bona fide representatives of print, electronic and broadcast media. To download a media registration form, go to: http://www.ecco-org.eu/binarydata.aspx?type=doc/Media_registration_form.pdf
NB: Media registration in advance is strongly recommended, and hotel rooms will go very quickly so early booking is recommended.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 27-Sep-2011[ | E-mail |
Share ] Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Media alert
Media have less than three weeks to register for Europe's largest cancer congress: The 2011 European Multidisciplinary Cancer Congress in Stockholm, 23-27 September 2011. To register, go to: www.ecco-org.eu
The 2011 European Multidisciplinary Cancer Congress will take place at the Stockholmsmssan (Stockholm International Fairs), Stockholm, Sweden, (www.stofair.se) from Friday 23 September to Tuesday 27 September 2011.
There will be over 2,000 presentations and around 16,000 participants from 120 countries, making it the largest European cancer congress to date. It is the only cancer congress in Europe to offer presentations of cutting-edge research across the whole cancer field, and will include basic and translational research, first reports from high quality phase II and III clinical trials, epidemiology and much more. In addition, for the first time there will be five new tracks, including industry and "oncotechnology". The "oncopolicy" track launched at the 2009 congress will continue to tackle issues of prime importance to the European cancer community, as well as helping to inform European policy and ensuring cancer's place at the top of the EU health and research policy agenda.
There will be media news briefings at the following times:
Friday 23 September: 13.00 hrs CEST Swedish language news briefing for local journalists
Friday 23 September: 17.00 hrs CEST Opening press conference
Saturday 24 September: 08.00 hrs CEST
Sunday 25 September: 08.00 hrs CEST
Monday 26 September: 08.00 hrs CEST
Monday 26 September: 11.15 hrs CEST
With the exception of the first press conference in Swedish for the local journalists, all other press conferences will be in English.
Here is a sample of some of the news to be announced at the congress (all information is embargoed):
- Is there a relationship between high blood pressure and the risk of developing or dying from cancer?
- New way of delivering treatment directly to the liver delivers extra months of disease-free life for melanoma patients
- Giving chemotherapy to pregnant women: what is the effect on their children?
- One size may not fit all: regular checks needed through the course of cancer to determine changes in tumour make-up and identify appropriate treatment
- New treatment can delay the onset of bone metastases in prostate cancer
- Results from two new Phase III trials reveal new ways of relieving pain from bone metastases in prostate cancer patients, and of improving their overall survival
- Results from phase III international trial shows significant benefits in quality of life for prostate cancer patients treated with new drug
- New drug combination can delay breast cancer progression in patients with advanced disease
- Potentially practice-changing results of major UK trial combining radiotherapy with chemotherapy in women with early breast cancer
- Latest update from the BIG 1-98 trial on the use of letrozole in post-menopausal women with early breast cancer
- Could smaller, faster trials improve patient survival by making new drugs available more quickly?
- Radical changes needed to develop equitable, affordable cancer care for all
- Standardising clinical practice across Europe: treatment of rectal cancer varies enormously between different countries
- Researchers discover gene that is mutated in some blood cancers and predicts better survival
- Two new, cost-effective ways to predict prostate cancer
- Elderly breast cancer patients are at risk of treatment discrimination
- Results from phase III trial of everolimus combined with exemestane: new hope for post-menopausal women with advanced breast cancer resistant to hormone therapy
- Does zoledronic acid added to standard adjuvant therapy reduce risk of recurrence in breast cancer patients?
Opening times for the congress press office in Stockholm and telephone numbers:
Friday 23 September 09.00 19.00 hrs (CEST)
Saturday 24 Monday 26 September 07.30 18.00 hrs
Tuesday 27 September 08.00 14.00 hrs
Tel: +46 (0)8 727 2107, +46 (0)8 727 2108 or +46 (0)8 727 2109
Fax: +46 (0)8 727 2138
Press officers: Emma Mason, Mary Rice, Kay Roche, Saffina Rana, Lisa Lnner Pulkkinen
The majority of the abstracts will be published online at 12.00 hrs CEST on Monday 12 September and can be reported from this time. You can find them at: http://stockholm2011.ecco-org.eu/programmesearch
However, any abstracts that are in the official media programme or that are late-breaking or "best" abstracts will not be published online until the day of presentation at the congress and are embargoed until that day.
###
ECCO (the European CanCer Organisation, which is organising the congress), ESMO and ESTRO welcome the interest of the press in cancer issues and are happy to provide full assistance to journalists attending the 2011 Stockholm congress, or using the congress website as a resource in their coverage of cancer issues. A media centre with computing, fax, photocopying and free international phone and internet connections will be available.
Follow us on Twitter: #emcc2011
Registration and hotel accommodation
The 2011 European Multidisciplinary Cancer Congress is open to bona fide representatives of print, electronic and broadcast media. To download a media registration form, go to: http://www.ecco-org.eu/binarydata.aspx?type=doc/Media_registration_form.pdf
NB: Media registration in advance is strongly recommended, and hotel rooms will go very quickly so early booking is recommended.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2011-09/eeco-mhl090211.php
vcu xanax benicio del toro aretha franklin bart the thing sprout
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.